Regional anesthesia in patients with preexisting neuropathy

International Anesthesiology Clinics

Volumn 49, Issue 4, 2011, Pages 144-165

  Lirk, Philipp ^a   Birmingham, Brian ^b   Hogan, Quinn ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; BUPIVACAINE; CALCIUM; FENTANYL; LIDOCAINE; MEPIVACAINE; OPIATE; ROPIVACAINE; SUFENTANIL;

BLOOD FLOW; CALCIUM SIGNALING; CELL DEATH; CONFERENCE PAPER; DIABETIC FOOT; DIABETIC NEUROPATHY; DISEASE CONTROL; DISEASE EXACERBATION; DRUG MEGADOSE; EPIDURAL ANESTHESIA; GENERAL ANESTHESIA; GUILLAIN BARRE SYNDROME; HIGH RISK PATIENT; HUMAN; LOCAL ANESTHESIA; LOW DRUG DOSE; MULTIPLE SCLEROSIS; NAUSEA; NERVE BLOCK; NERVE INJURY; NEUROPATHY; NEUROTOXICITY; NONHUMAN; PATIENT POSITIONING; POSTPOLIOMYELITIS SYNDROME; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PRURITUS; REGIONAL ANESTHESIA; RISK REDUCTION; SINGLE DRUG DOSE; SOMNOLENCE; TREATMENT PLANNING;

ANESTHESIA, CONDUCTION; ANESTHETICS, LOCAL; ANIMALS; DIABETIC NEUROPATHIES; GUILLAIN-BARRE SYNDROME; HUMANS; MULTIPLE SCLEROSIS; PERIPHERAL NERVE INJURIES; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 79959869137     PISSN: 00205907     EISSN: 15371913     Source Type: Journal    
DOI: 10.1097/AIA.0b013e3182101134     Document Type: Conference Paper

References (142)

1. Schug SA, Chong C. Pain management after ambulatory surgery. Curr Opin Anaesthesiol. 2009;22:738-743.
2. Mattila K, Hynynen M. Day surgery in Finland: a prospective cohort study of 14 day-surgery units. Acta Anaesthesiol Scand. 2009;53:455-463.
3. Wu CL, Berenholtz SM, Pronovost PJ, et al. Systematic review and analysis of postdischarge symptoms after outpatient surgery. Anesthesiology. 2002;96:994-1003. (Pubitemid 34266696)
4. Ilfeld BM, Enneking FK. Continuous peripheral nerve blocks at home: a review. Anesth Analg. 2005;100:1822-1833. (Pubitemid 40712747)
5. Kopp SL, Horlocker TT. Regional anaesthesia in day-stay and short-stay surgery. Anaesthesia. 2010;65(suppl 1):84-96.
6. Ansell GL, Montgomery JE. Outcome of ASA III patients undergoing day case surgery. Br J Anaesth. 2004;92:71-74. (Pubitemid 38054652)
7. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053. (Pubitemid 38579764)
8. Dripps RD, Vandam LD. Exacerbation of pre-existing neurologic disease after spinal anesthesia. N Engl J Med. 1956;255:843-849.
9. Selander D. Neurotoxicity of local anesthetics: animal data. Reg Anesth. 1993;18:461-468. (Pubitemid 24022584)
10. Hodgson PS, Neal JM, Pollock JE, et al. The neurotoxicity of drugs given intrathecally (spinal). Anesth Analg. 1999;88:797-809. (Pubitemid 29168851)
11. Werdehausen R, Fazeli S, Braun S, et al. Apoptosis induction by different local anaesthetics in a neuroblastoma cell line. Br J Anaesth. 2009;103:711-718.
12. Haller I, Hausott B, Tomaselli B, et al. Neurotoxicity of lidocaine involves specific activation of the p38 mitogen-activated protein kinase, but not extracellular signalregulated or c-jun N-Terminal kinases, and is mediated by arachidonic acid metabolites. Anesthesiology. 2006;105:1024-1033. (Pubitemid 44655515)
13. Lirk P, Haller I, Myers RR, et al. Mitigation of direct neurotoxic effects of lidocaine and amitriptyline by inhibition of p38 mitogen-activated protein kinase in vitro and in vivo. Anesthesiology. 2006;104:1266-1273. (Pubitemid 43852961)
14. Hogan QH. Pathophysiology of peripheral nerve injury during regional anesthesia. Reg Anesth Pain Med. 2008;33:435-441.
15. Gold MS, Reichling DB, Hampl KF, et al. Lidocaine toxicity in primary afferent neurons from the rat. J Pharmacol Exp Ther. 1998;285:413-421. (Pubitemid 28237413)
16. Lirk P, Haller I, Hausott B, et al. The neurotoxic effects of amitriptyline are mediated by apoptosis and are effectively blocked by inhibition of caspase activity. Anesth Analg. 2006;102:1728-1733. (Pubitemid 43799847)
17. Price SA, Agthong S, Middlemas AB, et al. Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase. Diabetes. 2004;53:1851-1856. (Pubitemid 38857044)
18. Upton AR, McComas AJ. The double crush in nerve entrapment syndromes. Lancet. 1973;2:359-362.
19. Gentili F, Hudson AR, Hunter D, et al. Nerve injection injury with local anesthetic agents: a light and electron microscopic, fluorescent microscopic, and horseradish peroxidase study. Neurosurgery. 1980;6:263-272. (Pubitemid 10133802)
20. Bigeleisen PE. Nerve puncture and apparent intraneural injection during ultrasound-guided axillary block does not invariably result in neurologic injury. Anesthesiology. 2006;105:779-783. (Pubitemid 44477324)
21. Sala-Blanch X, Ribalta T, Rivas E, et al. Structural injury to the human sciatic nerve after intraneural needle insertion. Reg Anesth Pain Med. 2009;34:201-205.
22. Warner MA, Warner ME, Martin JT. Ulnar neuropathy: incidence, outcome, and risk factors in sedated or anesthetized patients. Anesthesiology. 1994;81:1332-1340. (Pubitemid 24381423)
23. Blumenthal S, Lambert M, Borgeat A. Intraneural injection during anterior approach for sciatic nerve block: what have we learned and where to go from here? Anesthesiology. 2005;102:1283.
24. Bong CL, Seefelder C. Peripheral neuropathy following colonoscopy is not uncommon. Anesth Analg. 2009;108:384-385.
25. Boardman ND III, Cofield RH. Neurologic complications of shoulder surgery. Clin Orthop. 1999;368:44-53. (Pubitemid 29533978)
26. Sommerfield DL, McDonagh P, Heffernan AM, et al. Peripheral neuropathy masquerading as an epidural complication. Ir J Med Sci. 2010 April 22. [Epub ahead of print.]
27. Horlocker TT, Cabanela ME, Wedel DJ. Does postoperative epidural analgesia increase the risk of peroneal nerve palsy after total knee arthroplasty? Anesth Analg. 1994;79:495-500. (Pubitemid 24279848)
28. Kouri ME, Kopacz DJ. Spinal 2-chloroprocaine: a comparison with lidocaine in volunteers. Anesth Analg. 2004;98:75-80. (Pubitemid 38029848)
29. Pollock JE. Neurotoxicity of intrathecal local anaesthetics and transient neurological symptoms. Best Pract Res Clin Anaesthesiol. 2003;17:471-484. (Pubitemid 38950009)
30. Szypula K, Ashpole KJ, Bogod D, et al. Litigation related to regional anaesthesia: an analysis of claims against the NHS in England 1995-2007. Anaesthesia. 2010;65:443-452.
31. Brull R, McCartney CJ, Chan VW, et al. Neurological complications after regional anesthesia: contemporary estimates of risk. Anesth Analg. 2007;104:965-974. (Pubitemid 46548330)
32. Watts SA, Sharma DJ. Long-term neurological complications associated with surgery and peripheral nerve blockade: outcomes after 1065 consecutive blocks. Anaesth Intensive Care. 2007;35:24-31. (Pubitemid 46344281)
33. Barrington MJ, Watts SA, Gledhill SR, et al. Preliminary results of the australasian regional anaesthesia collaboration: a prospective audit of more than 7000 peripheral nerve and plexus blocks for neurologic and other complications. Reg Anesth Pain Med. 2009;34:534-541.
34. Compere V, Rey N, Baert O, et al. Major complications after 400 continuous popliteal sciatic nerve blocks for post-operative analgesia. Acta Anaesthesiol Scand. 2009;53:339-345.
35. Vandam LD, Dripps RD. Long-term follow-up of patients who received 10,098 spinal anesthetics; syndrome of decreased intracranial pressure (headache and ocular and auditory difficulties). J Am Med Assoc. 1956;161:586-591.
36. Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28:956-962. (Pubitemid 40434506)
37. Said G, Bigo A, Ameri A, et al. Uncommon early-onset neuropathy in diabetic patients. J Neurol. 1998;245:61-68. (Pubitemid 28118866)
38. Said G. Diabetic neuropathy: a review. Nat Clin Pract Neurol. 2007;3:331-340.
39. Tomlinson DR, Gardiner NJ. Diabetic neuropathies: components of etiology. J Peripher Nerv Syst. 2008;13:112-121. (Pubitemid 351871604)
40. Thamotharampillai K, Chan AK, Bennetts B, et al. Decline in neurophysiological function after 7 years in an adolescent diabetic cohort and the role of aldose reductase gene polymorphisms. Diabetes Care. 2006;29:2053-2057. (Pubitemid 44871186)
41. Hebl JR, Kopp SL, Schroeder DR, et al. Neurologic complications after neuraxial anesthesia or analgesia in patients with preexisting peripheral sensorimotor neuropathy or diabetic polyneuropathy. Anesth Analg. 2006;103:1294-1299. (Pubitemid 44627362)
42. Kalichman MW, Calcutt NA. Local anesthetic-induced conduction block and nerve fiber injury in streptozotocin-diabetic rats. Anesthesiology. 1992;77:941-947.
43. Lozeron P, Nahum L, Lacroix C, et al. Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients. J Neurol. 2002;249:569-575. (Pubitemid 34507831)
44. Kroin JS, Buvanendran A, Williams DK, et al. Local anesthetic sciatic nerve block and nerve fiber damage in diabetic rats. Reg Anesth Pain Med. 2010;35:343-350.
45. Blumenthal S, Borgeat A, Maurer K, et al. Preexisting subclinical neuropathy as a risk factor for nerve injury after continuous ropivacaine administration through a femoral nerve catheter. Anesthesiology. 2006;105:1053-1056. (Pubitemid 44655518)
46. Horlocker TT, ODriscoll SW, Dinapoli RP. Recurring brachial plexus neuropathy in a diabetic patient after shoulder surgery and continuous interscalene block. Anesth Analg. 2000;91:688-690.
47. Al-Nasser B. Toxic effects of epidural analgesia with ropivacaine 0.2% in a diabetic patient. J Clin Anesth. 2004;16:220-223. (Pubitemid 38813274)
48. Lena P, Teboul J, Mercier B, et al. [Motor deficit of the lower limbs and urinary incontinence following peridural anesthesia]. Ann Fr Anesth Reanim. 1998;17:1144-1147. (Pubitemid 29156495)
49. Waters JH, Watson TB, Ward MG. Conus medullaris injury following both tetracaine and lidocaine spinal anesthesia. J Clin Anesth. 1996;8:656-658. (Pubitemid 26427837)
50. Gebhard RE, Nielsen KC, Pietrobon R, et al. Diabetes mellitus, independent of body mass index, is associated with a "higher success" rate for supraclavicular brachial plexus blocks. Reg Anesth Pain Med. 2009;34:404-407.
51. Lok C, Kirk P. Problems performing a sciatic nerve block in an amputee. Anaesthesia. 2003;58:289-290. (Pubitemid 36329287)
52. Sites BD, Gallagher J, Sparks M. Ultrasound-guided popliteal block demonstrates an atypical motor response to nerve stimulation in 2 patients with diabetes mellitus. Reg Anesth Pain Med. 2003;28:479-482. (Pubitemid 37211095)
53. Knuttgen D, Bremerich D, Rings J, et al. Failure of relaxometry in diabetic polyneuropathy. Anaesthesist. 1992;41:559-563.
54. Hogan Q. Finding nerves is not simple. Reg Anesth Pain Med. 2003;28:367-371. (Pubitemid 37211075)
55. Rigaud M, Filip P, Lirk P, et al. Guidance of block needle insertion by electrical nerve stimulation: a pilot study of the resulting distribution of injected solution in dogs. Anesthesiology. 2008;109:473-478.
56. Bigeleisen PE, Moayeri N, Groen GJ. Extraneural versus intraneural stimulation thresholds during ultrasound-guided supraclavicular block. Anesthesiology. 2009;110: 1235-1243.
57. Szerb J, Persaud D. Long current impulses may be required for nerve stimulation in patients with ischemic pain. Can J Anaesth. 2005;52:963-966. (Pubitemid 43055825)
58. Hadzic A. ed. Putzu/Casati, Chapter 10, Textbook of Regional Anesthesia and Acute Pain Management. New York: The McGraw-Hill Companies 2007.
59. Brian A. Williams MD, MBA on 18 October 2010 at the Annual Meeting of the American Society of Anesthesiologists (San Diego, CA) Point-Counterpoint Session entitled "Peripheral Neuropathy and Regional Anesthesia and Analgesia: Is it Safe?"
60. Koscielniak-Nielsen ZJ. Ultrasound-guided peripheral nerve blocks: what are the benefits? Acta Anaesthesiol Scand. 2008;52:727-737. (Pubitemid 351829487)
61. Williams BA, Murinson BB, Grable BR, et al. Future considerations for pharmacologic adjuvants in single-injection peripheral nerve blocks for patients with diabetes mellitus. Reg Anesth Pain Med. 2009;34:445-457.
62. Myers RR, Heckman HM. Effects of local anesthesia on nerve blood flow: studies using lidocaine with and without epinephrine. Anesthesiology. 1989;71:757-762. (Pubitemid 19275099)
63. Nessler S, Bruck W. Advances in multiple sclerosis research in 2009. J Neurol. 2010;257:1590-1593.
64. Noseworthy JH, Lucchinetti C, Rodriguez M, et al. Multiple sclerosis. N Engl J Med. 2000;343:938-952.
65. Ingrosso M, Cirillo V, Papasso A, et al. Femoral and sciatic nerves block (BiBlock) in orthopedic traumatologic lower limbs surgery in patients with multiple sclerosis. Minerva Anestesiol. 2005;71:223-226. (Pubitemid 41557142)
66. Pollock M, Calder C, Allpress S. Peripheral nerve abnormality in multiple sclerosis. Ann Neurol. 1977;2:41-48.
67. Koff MD, Cohen JA, McIntyre JJ, et al. Severe brachial plexopathy after an ultrasound-guided single-injection nerve block for total shoulder arthroplasty in a patient with multiple sclerosis. Anesthesiology. 2008;108:325-328. (Pubitemid 351156743)
68. Sia S. Nerve blocks, ultrasounds, and multiple sclerosis. Anesthesiology. 2008;109: 751-752.
69. Borgeat A, Aguirre J, Neudorfer C, et al. Severe brachial plexopathy after an ultrasound-guided single-injection nerve block for total shoulder arthroplasty in a patient with multiple sclerosis: what is the likely cause of this complication? Anesthesiology. 2008;109:750-751.
70. Vogt J, Paul F, Aktas O, et al. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. Ann Neurol. 2009;66:310-322.
71. Gartzen K, Katzarava Z, Diener HC, et al. Peripheral nervous system involvement in multiple sclerosis. Eur J Neurol. 2011;5:789-791.
72. Kuczkowski KM. Labor analgesia for the parturient with neurological disease: what does an obstetrician need to know? Arch Gynecol Obstet. 2006;274:41-46.
73. Levesque P, Marsepoil T, Ho P, et al. Multiple sclerosis disclosed by spinal anesthesia. Ann Fr Anesth Reanim. 1988;7:68-70.
74. Perlas A, Chan VW. Neuraxial anesthesia and multiple sclerosis. Can J Anaesth. 2005;52:454-458. (Pubitemid 40883303)
75. Bamford C, Sibley W, Laguna J. Anesthesia in multiple sclerosis. Can J Neurol Sci. 1978;5:41-44.
76. Hebl JR, Horlocker TT, Schroeder DR. Neuraxial anesthesia and analgesia in patients with preexisting central nervous system disorders. Anesth Analg. 2006;103:223-228. (Pubitemid 44036063)
77. Confavreux C, Hutchinson M, Hours MM, et al. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med. 1998; 339:285-291. (Pubitemid 28366416)
78. Vukusic S, Confavreux C. Multiple sclerosis and pregnancy. Rev Neurol (Paris). 2006;162:299-309.
79. Nelson LM, Franklin GM, Jones MC. Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding. JAMA. 1988;259:3441-3443.
80. Drake E, Drake M, Bird J, et al. Obstetric regional blocks for women with multiple sclerosis: a survey of UK experience. Int J Obstet Anesth. 2006;15:115-123.
81. Wong CA. Nerve injuries after neuraxial anaesthesia and their medicolegal implications. Best Pract Res Clin Obstet Gynaecol. 2010;24:367-381.
82. MacArthur C, Lewis M, Knox EG. Health after childbirth. Br J Obstet Gynaecol. 1991;98:1193-1195.
83. Dalmas AF, Texier C, Ducloy-Bouthors AS, et al. Obstetrical analgesia and anaesthesia in multiple sclerosis. Ann Fr Anesth Reanim. 2003;22:861-864. (Pubitemid 37516850)
84. Bader AM, Hunt CO, Datta S, et al. Anesthesia for the obstetric patient with multiple sclerosis. J Clin Anesth. 1988;1:21-24.
85. Berger JM, Ontell R. Intrathecal morphine in conjunction with a combined spinal and general anesthetic in a patient with multiple sclerosis. Anesthesiology. 1987; 66:400-402. (Pubitemid 17095271)
86. Finucane BT, Terblanche OC. Prolonged duration of anesthesia in a patient with multiple sclerosis following paravertebral block. Can J Anaesth. 2005;52:493-497. (Pubitemid 40883310)
87. Williams BA, Tsui BYK, Hough K, et al. In Vitro Cytotoxicity Evaluation of Ropivacaine+ Clonidine-Buprenorphine-Dexamethasone-Midazolam. American Society of Anesthesiologists Annual Meeting, San Diego, 2010.
88. Sakurai M, Mannen T, Kanazawa I, et al. Lidocaine unmasks silent demyelinative lesions in multiple sclerosis. Neurology. 1992;42:2088-2093.
89. Hollmann MW, Wieczorek KS, Smart M, et al. Epidural anesthesia prevents hypercoagulation in patients undergoing major orthopedic surgery. Reg Anesth Pain Med. 2001;26:215-222. (Pubitemid 32476582)
90. Sakurai M, Kanazawa I. Positive symptoms in multiple sclerosis: their treatment with sodium channel blockers, lidocaine and mexiletine. J Neurol Sci. 1999;162:162-168. (Pubitemid 29125247)
91. Brinkmeier H, Aulkemeyer P, Wollinsky KH, et al. An endogenous pentapeptide acting as a sodium channel blocker in inflammatory autoimmune disorders of the central nervous system. Nat Med. 2000;6:808-811. (Pubitemid 30469431)
92. Gonzalez H, Olsson T, Borg K. Management of postpolio syndrome. Lancet Neurol. 2010;9:634-642.
93. Lambert DA, Giannouli E, Schmidt BJ. Postpolio syndrome and anesthesia. Anesthesiology. 2005;103:638-644. (Pubitemid 41243427)
94. Rezende DP, Rodrigues MR, Costa VV, et al. Patients with sequelae of poliomyelitis. Does the anesthetic technique impose risks? Rev Bras Anestesiol. 2008;58:210-219.
95. Connelly NR, Abbott TC. Successful use of succinylcholine for cesarean delivery in a patient with postpolio syndrome. Anesthesiology. 2008;108:1151-1152.
96. Gyermek L. Increased potency of nondepolarizing relaxants after poliomyelitis. J Clin Pharmacol. 1990;30:170-173. (Pubitemid 20143346)
97. De Troyer A, Kirkwood PA, Wilson TA. Respiratory action of the intercostal muscles. Physiol Rev. 2005;85:717-756. (Pubitemid 40404640)
98. Bordes J, Gaillard PE, Lacroix G, et al. Spinal anaesthesia guided by computed tomography scan in a patient with severe post-polio sequelae. Br J Anaesth. 2010;105:702-703.
99. Costello JF, Balki M. Cesarean delivery under ultrasound-guided spinal anesthesia in a parturient with poliomyelitis and Harrington instrumentation. Can J Anaesth. 2008;55:606-611.
100. Higashizawa T, Sugiura J, Takasugi Y. Spinal anesthesia in a patient with hemiparesis after poliomyelitis. Masui. 2003;52:1335-1337. (Pubitemid 38031246)
101. Van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome. Lancet Neurol. 2008;7:939-950.
102. Vucic S, Kiernan MC, Cornblath DR. Guillain-Barre syndrome: an update. J Clin Neurosci. 2009;16:733-741.
103. Van Doorn PA. Whats new in Guillain-Barre syndrome in 2007-2008? J Peripher Nerv Syst. 2009;14:72-74.
104. Kaji R, Nodera H. Puffer fish poisoning, Guillain-Barre syndrome and persistent sodium channels. Ann Neurol. 2005;57:309.
105. Perel A, Reches A, Davidson JT. Anaesthesia in the Guillian-Barre syndrome: a case report and recommendations. Anaesthesia. 1977;32:257-260. (Pubitemid 8038859)
106. Vassiliev DV, Nystrom EU, Leicht CH. Combined spinal and epidural anesthesia for labor and cesarean delivery in a patient with Guillain-Barre syndrome. Reg Anesth Pain Med. 2001;26:174-176. (Pubitemid 32230254)
107. Alici HA, Cesur M, Erdem AF, et al. Repeated use of epidural anaesthesia for caesarean delivery in a patient with Guillain-Barre syndrome. Int J Obstet Anesth. 2005;14:269-270. (Pubitemid 40933510)
108. McGrady EM. Management of labour and delivery in a patient with Guillain-Barre syndrome. Anaesthesia. 1987;42:899.
109. Wiertlewski S, Magot A, Drapier S, et al. Worsening of neurologic symptoms after epidural anesthesia for labor in a Guillain-Barre patient. Anesth Analg. 2004;98:825-827. (Pubitemid 38252684)
110. Gautier PE, Pierre PA, Van Obbergh LJ, et al. Guillain-Barre syndrome after obstetrical epidural analgesia. Reg Anesth. 1989;14:251-252. (Pubitemid 20125019)
111. Bamberger PD, Thys DM. Guillain-Barre syndrome in a patient with pancreatic cancer after an epidural-general anesthetic. Anesth Analg. 2005;100:1197-1199. (Pubitemid 40404234)
112. Steiner I, Argov Z, Cahan C, et al. Guillain-Barre syndrome after epidural anesthesia: direct nerve root damage may trigger disease. Neurology. 1985;35:1473-1475. (Pubitemid 15242425)
113. Kuok CH, Tsai PS, Hsu YW, et al. Postoperative delayed respiratory failure caused by Guillain-Barre syndrome: a case report. Acta Anaesthesiol Taiwan. 2007;45:43-46.
114. Hogan JC, Briggs TP, Oldershaw PJ. Guillain-Barre syndrome following cardiopulmonary bypass. Int J Cardiol. 1992;35:427-428.
115. Olivier N, Laribi H, Pages M, et al. [Recurrent Guillain-Barre syndrome after surgery]. Rev Neurol (Paris). 2010;166:644-647.
116. Brooks H, Christian AS, May AE. Pregnancy, anaesthesia and Guillain Barre syndrome. Anaesthesia. 2000;55:894-898.
117. Kocabas S, Karaman S, Firat V, et al. Anesthetic management of Guillain-Barre syndrome in pregnancy. J Clin Anesth. 2007;19:299-302. (Pubitemid 46899492)
118. Kattula A, Angelini G, Arndt G. Regional anesthesia in the presence of neurologic disease. In: Finucane BT. Complications of Regional Anesthesia. New York and Heidelberg: Springer Science Books; 1999.
119. Brull R, McCartney CJ, Chan VW, et al. Disclosure of risks associated with regional anesthesia: a survey of academic regional anesthesiologists. Reg Anesth Pain Med. 2007;32:7-11. (Pubitemid 44969585)
120. Neal JM, Bernards CM, Hadzic A, et al. ASRA practice advisory on neurologic complications in regional anesthesia and pain medicine. Reg Anesth Pain Med. 2008;33:404-415.
121. Bainton CR, Strichartz GR. Concentration dependence of lidocaine-induced irreversible conduction loss in frog nerve. Anesthesiology. 1994;81:657-667. (Pubitemid 24320676)
122. Kocum A, Turkoz A, Bozdogan N, et al. Femoral and sciatic nerve block with 0.25% bupivacaine for surgical management of diabetic foot syndrome: an anesthetic technique for high-risk patients with diabetic nephropathy. J Clin Anesth. 2010;22:363-366.
123. Neal JM. Effects of epinephrine in local anesthetics on the central and peripheral nervous systems: Neurotoxicity and neural blood flow. Reg Anesth Pain Med. 2003;28:124-134. (Pubitemid 36397788)
124. Partridge BL. The effects of local anesthetics and epinephrine on rat sciatic nerve blood flow. Anesthesiology. 1991;75:243-250.
125. Neal JM, Hebl JR, Gerancher JC, et al. Brachial plexus anesthesia: essentials of our current understanding. Reg Anesth Pain Med. 2002;27:402-428. (Pubitemid 34787393)
126. Rutten AJ, Nancarrow C, Mather LE, et al. Hemodynamic and central nervous system effects of intravenous bolus doses of lidocaine, bupivacaine, and ropivacaine in sheep. Anesth Analg. 1989;69:291-299. (Pubitemid 20033449)
127. Nancarrow C, Rutten AJ, Runciman WB, et al. Myocardial and cerebral drug concentrations and the mechanisms of death after fatal intravenous doses of lidocaine, bupivacaine, and ropivacaine in the sheep. Anesth Analg. 1989;69:276-283. (Pubitemid 20033447)
128. Singelyn FJ, Gouverneur JM, Robert A. A minimum dose of clonidine added to mepivacaine prolongs the duration of anesthesia and analgesia after axillary brachial plexus block. Anesth Analg. 1996;83:1046-1050. (Pubitemid 26365420)
129. Kroin JS, Buvanendran A, Beck DR, et al. Clonidine prolongation of lidocaine analgesia after sciatic nerve block in rats is mediated via the hyperpolarization-activated cation current, not by alpha-adrenoreceptors. Anesthesiology. 2004;101:488-494. (Pubitemid 38988506)
130. Williams BA. Toward a potential paradigm shift for the clinical care of diabetic patients requiring perineural analgesia: strategies for using the diabetic rodent model. Reg Anesth Pain Med. 2010;35:329-332.
131. Whiting DJ, Williams BA, Orebaugh SL, et al. Case report: postoperative analgesia and preserved motor function with clonidine and buprenorphine via a sciatic perineural catheter. J Clin Anesth. 2009;21:297-299.
132. Eaton SE, Harris ND, Rajbhandari SM, et al. Spinal-cord involvement in diabetic peripheral neuropathy. Lancet. 2001;358:35-36. (Pubitemid 32709739)
133. Lambert LA, Lambert DH, Strichartz GR. Irreversible conduction block in isolated nerve by high concentrations of local anesthetics. Anesthesiology. 1994;80:1082-1093. (Pubitemid 24150889)
134. Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990-1999. Anesthesiology. 2004;101:950-959. (Pubitemid 39288046)
135. Drasner K. Local anesthetic neurotoxicity: clinical injury and strategies that may minimize risk. Reg Anesth Pain Med. 2002;27:576-580. (Pubitemid 35387145)
136. Van Zundert AA, Grouls RJ, Korsten HH, et al. Spinal anesthesia. Volume or concentration: what matters? Reg Anesth. 1996;21:112-118.
137. Liu S, Pollock JE, Mulroy MF, et al. Comparison of 5% with dextrose, 1.5% with dextrose, and 1.5% dextrose-free lidocaine solutions for spinal anesthesia in human volunteers. Anesth Analg. 1995;81:697-702.
138. Korhonen AM. Use of spinal anaesthesia in day surgery. Curr Opin Anaesthesiol. 2006;19:612-616.
139. Ben-David B, Solomon E, Levin H, et al. Intrathecal fentanyl with small-dose dilute bupivacaine: better anesthesia without prolonging recovery. Anesth Analg. 1997;85:560-565. (Pubitemid 27381307)
140. Liu S, Chiu AA, Carpenter RL, et al. Fentanyl prolongs lidocaine spinal anesthesia without prolonging recovery. Anesth Analg. 1995;80:730-734.
141. Fukusima S, Takenami T, Nara Y. Neurotoxicity of intrathecally administered fentanyl and bupivacaine in the rat spinal model. American Society of Anesthesiologists Annual Meeting. San Diego; 2010.
142. Smith KN, Kopacz DJ, McDonald SB. Spinal 2-chloroprocaine: a dose-ranging study and the effect of added epinephrine. Anesth Analg. 2004;98:81-88. (Pubitemid 38029849)